Alzheimer’s is a brain disease that slowly destroys memory and thinking skills and eventually, basic functions. Currently, there is no way to prevent or cure it.
The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a brain health research study that is helping us better understand the disease. The study’s goals are to improve how doctors diagnose and treat a patient with Alzheimer’s disease and to provide data to researchers around the world.
ADNI4 is a 5-year study looking to recruit diverse participants. This is so our research better represents all people. This includes more Black, Latino/Hispanic, Asian, Pacific Islander/Native Hawaiian, and American Indian/Alaska Native participants.
This study involves cognitive tests, blood tests, and brain imaging. This is all at no cost to participants. It is longitudinal, which means we study people over time, ideally for years. We do this because we want to track changes in memory and thinking over time.
The learnings we gather are put into an anonymized database and shared with researchers. The scientific contributions from over 1,000 ADNI participants grow each year. More than 4,000 research discoveries can be attributed to ADNI since its start in 2004.
It is our hope that research using ADNI data will help lead to earlier diagnosis, treatments, and eventually ending Alzheimer’s disease.